1. Potential biomarkers for persistent and neuropathic pain therapy
   Marco Sisignano et al, 2019, Pharmacology & Therapeutics CrossRef
2. Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
   Susanna B Park et al, 2023, Journal of Neurology, Neurosurgery & Psychiatry CrossRef
3. Chemotherapy‐induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design
   Diane C. St. Germain et al, 2020, Cancer CrossRef
4. Neuromuscular complications of cancer therapy
   Andreas A. Argyriou et al, 2021, Current Opinion in Neurology CrossRef
5. Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice
   C. Meregalli et al, 2021, Neuroscience Letters CrossRef
6. A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy
   Paola Alberti, 2020, Expert Opinion on Drug Metabolism & Toxicology CrossRef
7. Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients
   Sofia Karteri et al, 2022, Journal of the Peripheral Nervous System CrossRef
8. Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study
   Tatsuma Edamura et al, 2022, Pain and Therapy CrossRef
9. Different genes may be involved in distal and local sensitization: A genome‐wide gene‐based association study and meta‐analysis
   Afroditi Kouraki et al, 2022, European Journal of Pain CrossRef